AusDiagnostics Pty Ltd

AusDiagnostics Pty Ltd specializes in multiplex immunoassay test kits designed for laboratory use. These kits allow simultaneous detection of multiple pathogens in clinical samples, including panels for sexually transmitted infections (STIs), viral infections (such as herpes, enterovirus, and adenovirus), respiratory pathogens, and cerebrospinal fluid controls. The products are structured in well-formatted formats (e.g., 8-well, 12-well, 16-well, or 24-well) and are tailored for specific diagnostic steps, such as Step 1 or Step 2 testing.

AusDiagnostics Pty Ltd is based in Australia. While the company’s location determines its primary regulatory jurisdiction under Australian standards, its devices are also registered in the EU’s eudamed database, indicating compliance with European In Vitro Diagnostic Regulation (IVDR) requirements. Registration in eudamed reflects the manufacturer’s adherence to EU regulatory processes, even if the devices are not necessarily cleared or approved by the EU directly—individual devices must meet specific regulatory criteria for authorization.

AusDiagnostics Pty Ltd’s devices fall under Class A classification, which is the lowest risk category for in vitro diagnostics (IVDs) under the EU’s IVDR. Additionally, some of its products are listed under Annex II List B and General IVD categories, indicating they may require additional scrutiny or specific labeling requirements due to their diagnostic purpose. These classifications help determine the regulatory pathway and compliance obligations for each device.

AusDiagnostics Pty Ltd’s devices are listed in the eudamed database, which is the official EU registry for in vitro diagnostic medical devices. This registry tracks devices that have undergone the necessary regulatory processes to comply with EU requirements, though listing alone does not imply authorization—it confirms the manufacturer’s participation in the EU’s regulatory framework. The company’s inclusion in eudamed ensures transparency and accessibility for healthcare professionals and regulatory bodies.

The ‘Step 1’ and ‘Step 2’ designations in AusDiagnostics Pty Ltd’s devices refer to specific stages in the diagnostic workflow for multiplex immunoassays. These steps are part of the testing protocol to ensure accurate detection of pathogens. For example, Step 1 may involve initial sample preparation or screening, while Step 2 could involve confirmation or further analysis. The structured format (e.g., well sizes) aligns with these procedural requirements to streamline laboratory testing.